Interaction of L-dopa and GHRH on GH secretion in normal men
- PMID: 2515218
- DOI: 10.1007/BF03350059
Interaction of L-dopa and GHRH on GH secretion in normal men
Abstract
To determine how L-dopa stimulates GH secretion, we investigated its interaction with GHRH in vivo. Six normal men were studied on 4 occasions: 1) L-dopa-TRH: 500 mg L-dopa orally followed by 200 micrograms TRH 60 min later; 2) L-dopa-GHRH-TRH: 100 micrograms GHRH 1-44 iv 30 min after L-dopa followed by 200 micrograms TRH iv; 3) GHRH-TRH: 100 micrograms GHRH iv at 0 min, 30 min later 200 micrograms TRH iv; 4) TRH test: 200 micrograms TRH iv as a bolus. After L-dopa-TRH GH-levels increased significantly from 0.6 micrograms/l to 25.8 +/- 9.6 (SE) micrograms/l at 60 min. Only a slight TSH and no PRL increase was observed after L-dopa-TRH. After L-dopa-GHRH-TRH the GH-increase was significantly higher (45.7 +/- 11.1 micrograms/l) compared to L-dopa-TRH alone. GHRH-TRH increased GH-levels to 52.5 +/- 12.1 micrograms/l, which was not significantly different from the GH-levels obtained when L-dopa-GHRH-TRH were given. TRH increased serum TSH and PRL to 6.3 +/- 0.7 microU/ml and 715 +/- 136 microU/ml, respectively, which was significantly higher compared to the TSH responses after L-dopa-TRH. The PRL and TSH increase after TRH only was also higher (TSH-max: 5.7 +/- 0.5 microU/ml; PRL-max: 899 +/- 154 microU/ml) compared to the TSH and PRL responses after L-dopa-TRH. Our results show that the combination of L-dopa with GHRH leads to the same GH response as GHRH only. However, both responses are significantly higher than the one after L-dopa alone.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion.J Clin Endocrinol Metab. 1988 Dec;67(6):1186-9. doi: 10.1210/jcem-67-6-1186. J Clin Endocrinol Metab. 1988. PMID: 2903866
-
Effect of simultaneous administration of GHRH (1-40) and TRH on GH, PRL and TSH secretion in normal man.J Endocrinol Invest. 1986 Dec;9(6):497-501. doi: 10.1007/BF03346973. J Endocrinol Invest. 1986. PMID: 3106459 Clinical Trial.
-
Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion.J Clin Endocrinol Metab. 1990 Jul;71(1):157-63. doi: 10.1210/jcem-71-1-157. J Clin Endocrinol Metab. 1990. PMID: 1973420
-
[Hyperresponsiveness of TSH and prolactin and impaired responsiveness of GH in Japanese patients with isolated ACTH deficiency].Nihon Naibunpi Gakkai Zasshi. 1992 Oct 20;68(10):1096-111. doi: 10.1507/endocrine1927.68.10_1096. Nihon Naibunpi Gakkai Zasshi. 1992. PMID: 1333997 Review. Japanese.
-
Secretagogue induction of GH release in QNR/D cells: prevention of cell death.Gen Comp Endocrinol. 2014 Jul 1;203:274-80. doi: 10.1016/j.ygcen.2014.04.004. Epub 2014 Apr 19. Gen Comp Endocrinol. 2014. PMID: 24755186 Review.
Cited by
-
Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli.J Clin Invest. 1996 Feb 15;97(4):934-40. doi: 10.1172/JCI118516. J Clin Invest. 1996. PMID: 8613546 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources